▶ 調査レポート

ヘルペスマーカー検査の世界市場(~2026年)

• 英文タイトル:Global Herpes Marker Testing Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ヘルペスマーカー検査の世界市場(~2026年) / Global Herpes Marker Testing Market Size, Status and Forecast 2020-2026 / MRC2-11QY12179資料のイメージです。• レポートコード:MRC2-11QY12179
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、132ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はヘルペスマーカー検査のグローバル市場について調査・分析したレポートです。種類別(HSV-1、HSV-2、HSV-1/HSV-2)市場規模、用途別(研究、クリニック)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ヘルペスマーカー検査の競争状況、市場シェア
・世界のヘルペスマーカー検査市場:種類別市場規模 2015年-2020年(HSV-1、HSV-2、HSV-1/HSV-2)
・世界のヘルペスマーカー検査市場:種類別市場規模予測 2021年-2026年(HSV-1、HSV-2、HSV-1/HSV-2)
・世界のヘルペスマーカー検査市場:用途別市場規模 2015年-2020年(研究、クリニック)
・世界のヘルペスマーカー検査市場:用途別市場規模予測 2021年-2026年(研究、クリニック)
・北米のヘルペスマーカー検査市場分析:米国、カナダ
・ヨーロッパのヘルペスマーカー検査市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのヘルペスマーカー検査市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のヘルペスマーカー検査市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのヘルペスマーカー検査市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Abbott Laboratories、Abcam Plc、BioMérieux SA、Thermo Fisher Scientific, Inc.、F. Hoffmann-La Roche Ltd.、DiaSorin S.p.A.、Quidel Corporation、Luminex Corporation、Merck KGaA、Qiagen N.V.、Norgen Biotek Corp.、Hologic Inc.、Bio Rad Laboratories Inc.、Meridian Bioscience Inc、Teco Diagnostics
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits.

Market Analysis and Insights: Global Herpes Marker Testing Market
The global Herpes Marker Testing market size is projected to reach US$ 77 million by 2026, from US$ 74 million in 2020, at a CAGR of 3.3%% during 2021-2026.

Global Herpes Marker Testing Scope and Market Size
Herpes Marker Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Marker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott Laboratories
Abcam Plc
BioMérieux SA
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
Quidel Corporation
Luminex Corporation
Merck KGaA
Qiagen N.V.
Norgen Biotek Corp.
Hologic Inc.
Bio Rad Laboratories Inc.
Meridian Bioscience Inc
Teco Diagnostics

Market segment by Type, the product can be split into
HSV-1
HSV-2
HSV-1/ HSV-2
Market segment by Application, split into
Research
Clinic

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Herpes Marker Testing Revenue
1.4 Market by Type
1.4.1 Global Herpes Marker Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 HSV-1
1.4.3 HSV-2
1.4.4 HSV-1/ HSV-2
1.5 Market by Application
1.5.1 Global Herpes Marker Testing Market Share by Application: 2020 VS 2026
1.5.2 Research
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Herpes Marker Testing Market Perspective (2015-2026)
2.2 Global Herpes Marker Testing Growth Trends by Regions
2.2.1 Herpes Marker Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Herpes Marker Testing Historic Market Share by Regions (2015-2020)
2.2.3 Herpes Marker Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Herpes Marker Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Herpes Marker Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Herpes Marker Testing Players by Market Size
3.1.1 Global Top Herpes Marker Testing Players by Revenue (2015-2020)
3.1.2 Global Herpes Marker Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Herpes Marker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Herpes Marker Testing Market Concentration Ratio
3.2.1 Global Herpes Marker Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Herpes Marker Testing Revenue in 2019
3.3 Herpes Marker Testing Key Players Head office and Area Served
3.4 Key Players Herpes Marker Testing Product Solution and Service
3.5 Date of Enter into Herpes Marker Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Herpes Marker Testing Historic Market Size by Type (2015-2020)
4.2 Global Herpes Marker Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Herpes Marker Testing Market Size by Application (2015-2020)
5.2 Global Herpes Marker Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Herpes Marker Testing Market Size (2015-2020)
6.2 Herpes Marker Testing Key Players in North America (2019-2020)
6.3 North America Herpes Marker Testing Market Size by Type (2015-2020)
6.4 North America Herpes Marker Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Herpes Marker Testing Market Size (2015-2020)
7.2 Herpes Marker Testing Key Players in Europe (2019-2020)
7.3 Europe Herpes Marker Testing Market Size by Type (2015-2020)
7.4 Europe Herpes Marker Testing Market Size by Application (2015-2020)

8 China
8.1 China Herpes Marker Testing Market Size (2015-2020)
8.2 Herpes Marker Testing Key Players in China (2019-2020)
8.3 China Herpes Marker Testing Market Size by Type (2015-2020)
8.4 China Herpes Marker Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Herpes Marker Testing Market Size (2015-2020)
9.2 Herpes Marker Testing Key Players in Japan (2019-2020)
9.3 Japan Herpes Marker Testing Market Size by Type (2015-2020)
9.4 Japan Herpes Marker Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Herpes Marker Testing Market Size (2015-2020)
10.2 Herpes Marker Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Herpes Marker Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Herpes Marker Testing Market Size by Application (2015-2020)

11 India
11.1 India Herpes Marker Testing Market Size (2015-2020)
11.2 Herpes Marker Testing Key Players in India (2019-2020)
11.3 India Herpes Marker Testing Market Size by Type (2015-2020)
11.4 India Herpes Marker Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Herpes Marker Testing Market Size (2015-2020)
12.2 Herpes Marker Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Herpes Marker Testing Market Size by Type (2015-2020)
12.4 Central & South America Herpes Marker Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Herpes Marker Testing Introduction
13.1.4 Abbott Laboratories Revenue in Herpes Marker Testing Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Abcam Plc
13.2.1 Abcam Plc Company Details
13.2.2 Abcam Plc Business Overview
13.2.3 Abcam Plc Herpes Marker Testing Introduction
13.2.4 Abcam Plc Revenue in Herpes Marker Testing Business (2015-2020)
13.2.5 Abcam Plc Recent Development
13.3 BioMérieux SA
13.3.1 BioMérieux SA Company Details
13.3.2 BioMérieux SA Business Overview
13.3.3 BioMérieux SA Herpes Marker Testing Introduction
13.3.4 BioMérieux SA Revenue in Herpes Marker Testing Business (2015-2020)
13.3.5 BioMérieux SA Recent Development
13.4 Thermo Fisher Scientific, Inc.
13.4.1 Thermo Fisher Scientific, Inc. Company Details
13.4.2 Thermo Fisher Scientific, Inc. Business Overview
13.4.3 Thermo Fisher Scientific, Inc. Herpes Marker Testing Introduction
13.4.4 Thermo Fisher Scientific, Inc. Revenue in Herpes Marker Testing Business (2015-2020)
13.4.5 Thermo Fisher Scientific, Inc. Recent Development
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Details
13.5.2 F. Hoffmann-La Roche Ltd. Business Overview
13.5.3 F. Hoffmann-La Roche Ltd. Herpes Marker Testing Introduction
13.5.4 F. Hoffmann-La Roche Ltd. Revenue in Herpes Marker Testing Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Ltd. Recent Development
13.6 DiaSorin S.p.A.
13.6.1 DiaSorin S.p.A. Company Details
13.6.2 DiaSorin S.p.A. Business Overview
13.6.3 DiaSorin S.p.A. Herpes Marker Testing Introduction
13.6.4 DiaSorin S.p.A. Revenue in Herpes Marker Testing Business (2015-2020)
13.6.5 DiaSorin S.p.A. Recent Development
13.7 Quidel Corporation
13.7.1 Quidel Corporation Company Details
13.7.2 Quidel Corporation Business Overview
13.7.3 Quidel Corporation Herpes Marker Testing Introduction
13.7.4 Quidel Corporation Revenue in Herpes Marker Testing Business (2015-2020)
13.7.5 Quidel Corporation Recent Development
13.8 Luminex Corporation
13.8.1 Luminex Corporation Company Details
13.8.2 Luminex Corporation Business Overview
13.8.3 Luminex Corporation Herpes Marker Testing Introduction
13.8.4 Luminex Corporation Revenue in Herpes Marker Testing Business (2015-2020)
13.8.5 Luminex Corporation Recent Development
13.9 Merck KGaA
13.9.1 Merck KGaA Company Details
13.9.2 Merck KGaA Business Overview
13.9.3 Merck KGaA Herpes Marker Testing Introduction
13.9.4 Merck KGaA Revenue in Herpes Marker Testing Business (2015-2020)
13.9.5 Merck KGaA Recent Development
13.10 Qiagen N.V.
13.10.1 Qiagen N.V. Company Details
13.10.2 Qiagen N.V. Business Overview
13.10.3 Qiagen N.V. Herpes Marker Testing Introduction
13.10.4 Qiagen N.V. Revenue in Herpes Marker Testing Business (2015-2020)
13.10.5 Qiagen N.V. Recent Development
13.11 Norgen Biotek Corp.
10.11.1 Norgen Biotek Corp. Company Details
10.11.2 Norgen Biotek Corp. Business Overview
10.11.3 Norgen Biotek Corp. Herpes Marker Testing Introduction
10.11.4 Norgen Biotek Corp. Revenue in Herpes Marker Testing Business (2015-2020)
10.11.5 Norgen Biotek Corp. Recent Development
13.12 Hologic Inc.
10.12.1 Hologic Inc. Company Details
10.12.2 Hologic Inc. Business Overview
10.12.3 Hologic Inc. Herpes Marker Testing Introduction
10.12.4 Hologic Inc. Revenue in Herpes Marker Testing Business (2015-2020)
10.12.5 Hologic Inc. Recent Development
13.13 Bio Rad Laboratories Inc.
10.13.1 Bio Rad Laboratories Inc. Company Details
10.13.2 Bio Rad Laboratories Inc. Business Overview
10.13.3 Bio Rad Laboratories Inc. Herpes Marker Testing Introduction
10.13.4 Bio Rad Laboratories Inc. Revenue in Herpes Marker Testing Business (2015-2020)
10.13.5 Bio Rad Laboratories Inc. Recent Development
13.14 Meridian Bioscience Inc
10.14.1 Meridian Bioscience Inc Company Details
10.14.2 Meridian Bioscience Inc Business Overview
10.14.3 Meridian Bioscience Inc Herpes Marker Testing Introduction
10.14.4 Meridian Bioscience Inc Revenue in Herpes Marker Testing Business (2015-2020)
10.14.5 Meridian Bioscience Inc Recent Development
13.15 Teco Diagnostics
10.15.1 Teco Diagnostics Company Details
10.15.2 Teco Diagnostics Business Overview
10.15.3 Teco Diagnostics Herpes Marker Testing Introduction
10.15.4 Teco Diagnostics Revenue in Herpes Marker Testing Business (2015-2020)
10.15.5 Teco Diagnostics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Herpes Marker Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Herpes Marker Testing Revenue
Table 3. Ranking of Global Top Herpes Marker Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Herpes Marker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HSV-1
Table 6. Key Players of HSV-2
Table 7. Key Players of HSV-1/ HSV-2
Table 8. Global Herpes Marker Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Herpes Marker Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Herpes Marker Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Herpes Marker Testing Market Share by Regions (2015-2020)
Table 12. Global Herpes Marker Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Herpes Marker Testing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Herpes Marker Testing Market Growth Strategy
Table 18. Main Points Interviewed from Key Herpes Marker Testing Players
Table 19. Global Herpes Marker Testing Revenue by Players (2015-2020) (Million US$)
Table 20. Global Herpes Marker Testing Market Share by Players (2015-2020)
Table 21. Global Top Herpes Marker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Marker Testing as of 2019)
Table 22. Global Herpes Marker Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Herpes Marker Testing Product Solution and Service
Table 25. Date of Enter into Herpes Marker Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Herpes Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 28. Global Herpes Marker Testing Market Size Share by Type (2015-2020)
Table 29. Global Herpes Marker Testing Revenue Market Share by Type (2021-2026)
Table 30. Global Herpes Marker Testing Market Size Share by Application (2015-2020)
Table 31. Global Herpes Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 32. Global Herpes Marker Testing Market Size Share by Application (2021-2026)
Table 33. North America Key Players Herpes Marker Testing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Herpes Marker Testing Market Share (2019-2020)
Table 35. North America Herpes Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 36. North America Herpes Marker Testing Market Share by Type (2015-2020)
Table 37. North America Herpes Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 38. North America Herpes Marker Testing Market Share by Application (2015-2020)
Table 39. Europe Key Players Herpes Marker Testing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Herpes Marker Testing Market Share (2019-2020)
Table 41. Europe Herpes Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Herpes Marker Testing Market Share by Type (2015-2020)
Table 43. Europe Herpes Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Herpes Marker Testing Market Share by Application (2015-2020)
Table 45. China Key Players Herpes Marker Testing Revenue (2019-2020) (Million US$)
Table 46. China Key Players Herpes Marker Testing Market Share (2019-2020)
Table 47. China Herpes Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 48. China Herpes Marker Testing Market Share by Type (2015-2020)
Table 49. China Herpes Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 50. China Herpes Marker Testing Market Share by Application (2015-2020)
Table 51. Japan Key Players Herpes Marker Testing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Herpes Marker Testing Market Share (2019-2020)
Table 53. Japan Herpes Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Herpes Marker Testing Market Share by Type (2015-2020)
Table 55. Japan Herpes Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Herpes Marker Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Herpes Marker Testing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Herpes Marker Testing Market Share (2019-2020)
Table 59. Southeast Asia Herpes Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Herpes Marker Testing Market Share by Type (2015-2020)
Table 61. Southeast Asia Herpes Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Herpes Marker Testing Market Share by Application (2015-2020)
Table 63. India Key Players Herpes Marker Testing Revenue (2019-2020) (Million US$)
Table 64. India Key Players Herpes Marker Testing Market Share (2019-2020)
Table 65. India Herpes Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 66. India Herpes Marker Testing Market Share by Type (2015-2020)
Table 67. India Herpes Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 68. India Herpes Marker Testing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Herpes Marker Testing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Herpes Marker Testing Market Share (2019-2020)
Table 71. Central & South America Herpes Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Herpes Marker Testing Market Share by Type (2015-2020)
Table 73. Central & South America Herpes Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Herpes Marker Testing Market Share by Application (2015-2020)
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Product
Table 78. Abbott Laboratories Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 79. Abbott Laboratories Recent Development
Table 80. Abcam Plc Company Details
Table 81. Abcam Plc Business Overview
Table 82. Abcam Plc Product
Table 83. Abcam Plc Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 84. Abcam Plc Recent Development
Table 85. BioMérieux SA Company Details
Table 86. BioMérieux SA Business Overview
Table 87. BioMérieux SA Product
Table 88. BioMérieux SA Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 89. BioMérieux SA Recent Development
Table 90. Thermo Fisher Scientific, Inc. Company Details
Table 91. Thermo Fisher Scientific, Inc. Business Overview
Table 92. Thermo Fisher Scientific, Inc. Product
Table 93. Thermo Fisher Scientific, Inc. Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 94. Thermo Fisher Scientific, Inc. Recent Development
Table 95. F. Hoffmann-La Roche Ltd. Company Details
Table 96. F. Hoffmann-La Roche Ltd. Business Overview
Table 97. F. Hoffmann-La Roche Ltd. Product
Table 98. F. Hoffmann-La Roche Ltd. Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 99. F. Hoffmann-La Roche Ltd. Recent Development
Table 100. DiaSorin S.p.A. Company Details
Table 101. DiaSorin S.p.A. Business Overview
Table 102. DiaSorin S.p.A. Product
Table 103. DiaSorin S.p.A. Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 104. DiaSorin S.p.A. Recent Development
Table 105. Quidel Corporation Company Details
Table 106. Quidel Corporation Business Overview
Table 107. Quidel Corporation Product
Table 108. Quidel Corporation Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 109. Quidel Corporation Recent Development
Table 110. Luminex Corporation Business Overview
Table 111. Luminex Corporation Product
Table 112. Luminex Corporation Company Details
Table 113. Luminex Corporation Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 114. Luminex Corporation Recent Development
Table 115. Merck KGaA Company Details
Table 116. Merck KGaA Business Overview
Table 117. Merck KGaA Product
Table 118. Merck KGaA Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 119. Merck KGaA Recent Development
Table 120. Qiagen N.V. Company Details
Table 121. Qiagen N.V. Business Overview
Table 122. Qiagen N.V. Product
Table 123. Qiagen N.V. Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 124. Qiagen N.V. Recent Development
Table 125. Norgen Biotek Corp. Company Details
Table 126. Norgen Biotek Corp. Business Overview
Table 127. Norgen Biotek Corp. Product
Table 128. Norgen Biotek Corp. Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 129. Norgen Biotek Corp. Recent Development
Table 130. Hologic Inc. Company Details
Table 131. Hologic Inc. Business Overview
Table 132. Hologic Inc. Product
Table 133. Hologic Inc. Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 134. Hologic Inc. Recent Development
Table 135. Bio Rad Laboratories Inc. Company Details
Table 136. Bio Rad Laboratories Inc. Business Overview
Table 137. Bio Rad Laboratories Inc. Product
Table 138. Bio Rad Laboratories Inc. Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 139. Bio Rad Laboratories Inc. Recent Development
Table 140. Meridian Bioscience Inc Company Details
Table 141. Meridian Bioscience Inc Business Overview
Table 142. Meridian Bioscience Inc Product
Table 143. Meridian Bioscience Inc Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 144. Meridian Bioscience Inc Recent Development
Table 145. Teco Diagnostics Company Details
Table 146. Teco Diagnostics Business Overview
Table 147. Teco Diagnostics Product
Table 148. Teco Diagnostics Revenue in Herpes Marker Testing Business (2015-2020) (Million US$)
Table 149. Teco Diagnostics Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Marker Testing Market Share by Type: 2020 VS 2026
Figure 2. HSV-1 Features
Figure 3. HSV-2 Features
Figure 4. HSV-1/ HSV-2 Features
Figure 5. Global Herpes Marker Testing Market Share by Application: 2020 VS 2026
Figure 6. Research Case Studies
Figure 7. Clinic Case Studies
Figure 8. Herpes Marker Testing Report Years Considered
Figure 9. Global Herpes Marker Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Herpes Marker Testing Market Share by Regions: 2020 VS 2026
Figure 11. Global Herpes Marker Testing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Herpes Marker Testing Market Share by Players in 2019
Figure 14. Global Top Herpes Marker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Marker Testing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Herpes Marker Testing Revenue in 2019
Figure 16. North America Herpes Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Herpes Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Herpes Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Herpes Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Herpes Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Herpes Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Herpes Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed